Stella Diagnostics, Inc. (SLDX)
0.0081
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Stella Diagnostics Net Income (Quarterly) : -0.978M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.978M |
| March 31, 2026 | -1.090M |
| December 31, 2025 | -1.599M |
| September 30, 2025 | -0.6882M |
| June 30, 2025 | -1.123M |
| March 31, 2025 | -0.6471M |
| December 31, 2024 | -0.2302M |
| September 30, 2024 | -0.2803M |
| June 30, 2024 | -0.4209M |
| March 31, 2024 | -0.3043M |
| December 31, 2023 | -1.622M |
| September 30, 2023 | -0.8164M |
| June 30, 2023 | -0.3904M |
| March 31, 2023 | -2.879M |
| December 31, 2022 | -1.036M |
| September 30, 2022 | -0.7319M |
| June 30, 2022 | -0.1109M |
| March 31, 2022 | -3.944M |
| September 30, 2021 | -0.1954M |
| June 30, 2021 | -0.4429M |
| March 31, 2021 | -0.378M |
| September 30, 2020 | -6.538M |
| June 30, 2020 | -0.8807M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0031M |
| December 31, 2019 | -1.082M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0767M |
| March 31, 2019 | -0.8305M |
| March 31, 2018 | -0.2203M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.0053M |
| March 31, 2016 | -0.0001M |
| September 30, 2015 | 1.252M |
| June 30, 2015 | -0.0307M |
| March 31, 2015 | -0.0333M |
| December 31, 2014 | -0.1212M |
| September 30, 2014 | -0.0037M |
| June 30, 2014 | -0.0085M |
| March 31, 2014 | -0.0652M |
| December 31, 2013 | -0.0383M |
| September 30, 2013 | -0.1597M |
| June 30, 2013 | -0.03M |
| March 31, 2013 | -0.03M |
| June 30, 2012 | -0.1686M |
| March 31, 2012 | -0.1686M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0086M |
| Xcelerate, Inc. | -0.0542M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0214M |
| Vivos Therapeutics, Inc. | -5.523M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.5011M |
| Total Expenses (Quarterly) | 1.479M |
| EPS Diluted (Quarterly) | -0.0032 |
| Enterprise Value | 20.44M |
| Gross Profit Margin (Quarterly) | -14.09% |
| Profit Margin (Quarterly) | -195.2% |
| Earnings Yield | -175.0% |
| Normalized Earnings Yield | -174.98 |